Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to camp"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.992 | ||
| EGR1 | early growth response 1 | 0.981 | Human Rat | |
| JUNB | jun B proto-oncogene | 0.974 | ||
| KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.941 | ||
| ATF3 | activating transcription factor 3 | 0.879 | ||
| CCNE1 | cyclin E1 | 0.870 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.830 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.809 | ||
| KCNE1 | potassium voltage-gated channel, Isk-related family, member 1 | 0.804 | ||
| JUN | jun proto-oncogene | 0.732 | Rat | |
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.638 | Rat | |
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.605 | Rat | |
| PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.603 | ||
| C1R | complement component 1, r subcomponent | 0.581 | ||
| ANGPT2 | angiopoietin 2 | 0.572 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.562 | ||
| EGR3 | early growth response 3 | 0.467 | Human | |
| NOSTRIN | nitric oxide synthase trafficker | 0.409 | ||
| CCND1 | cyclin D1 | 0.404 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.400 | ||
| IER2 | immediate early response 2 | 0.361 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.337 | ||
| PLAT | plasminogen activator, tissue | 0.335 | Rat | |
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.325 | ||
| EGR2 | early growth response 2 | 0.312 | Human | |
| AXL | AXL receptor tyrosine kinase | 0.220 | ||
| DRD2 | dopamine receptor D2 | 0.220 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.215 | Rat | |
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.212 | ||
| RAP1A | RAP1A, member of RAS oncogene family | 0.205 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.194 | ||
| PRKAR2A | protein kinase, cAMP-dependent, regulatory, type II, alpha | 0.178 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.175 | ||
| PLAU | plasminogen activator, urokinase | 0.165 | ||
| ANGPT1 | angiopoietin 1 | 0.160 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.154 | ||
| PHYHIPL | phytanoyl-CoA 2-hydroxylase interacting protein-like | 0.137 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.132 | ||
| TRPC4 | transient receptor potential cation channel, subfamily C, member 4 | 0.123 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.121 | Rat | |
| MAPK3 | mitogen-activated protein kinase 3 | 0.121 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.119 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.114 | Human | |
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.109 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.109 | ||
| SPTBN4 | spectrin, beta, non-erythrocytic 4 | 0.106 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.106 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.104 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.101 | ||
| AGXT2 | alanine--glyoxylate aminotransferase 2 | 0.101 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.098 | ||
| PDZK1 | PDZ domain containing 1 | 0.093 | ||
| GAST | gastrin | 0.090 | ||
| BTG2 | BTG family, member 2 | 0.089 | ||
| RB1 | retinoblastoma 1 | 0.085 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.083 | ||
| JUND | jun D proto-oncogene | 0.082 | ||
| UQCRB | ubiquinol-cytochrome c reductase binding protein | 0.078 | ||
| DNM1 | dynamin 1 | 0.077 | ||
| ADAM12 | ADAM metallopeptidase domain 12 | 0.073 | ||
| FBXW7 | F-box and WD repeat domain containing 7 | 0.070 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.068 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.066 | ||
| PROX1 | prospero homeobox 1 | 0.065 | ||
| RUNDC3A | RUN domain containing 3A | 0.064 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.063 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.061 | ||
| INO80B | INO80 complex subunit B | 0.056 | ||
| CCND3 | cyclin D3 | 0.056 | ||
| BBS1 | Bardet-Biedl syndrome 1 | 0.054 | ||
| FN1 | fibronectin 1 | 0.054 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.053 | ||
| ATF2 | activating transcription factor 2 | 0.053 | ||
| BCR | breakpoint cluster region | 0.053 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.053 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.053 | ||
| RHOB | ras homolog gene family, member B | 0.049 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.049 | ||
| PCGF2 | polycomb group ring finger 2 | 0.047 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.046 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.046 | ||
| BCL2L1 | BCL2-like 1 | 0.046 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.045 | ||
| FOSL2 | FOS-like antigen 2 | 0.044 | ||
| KLF6 | Kruppel-like factor 6 | 0.044 | ||
| PRKCE | protein kinase C, epsilon | 0.042 | ||
| THBS1 | thrombospondin 1 | 0.040 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.040 | ||
| KSR1 | kinase suppressor of ras 1 | 0.040 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.040 | ||
| C3orf15 | chromosome 3 open reading frame 15 | 0.038 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.037 | ||
| AQP7 | aquaporin 7 | 0.037 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.036 | ||
| DUSP5 | dual specificity phosphatase 5 | 0.036 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.036 | Rat | |
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.034 | ||
| ABI1 | abl-interactor 1 | 0.034 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.034 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.034 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.033 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.033 | ||
| CDC25A | cell division cycle 25 homolog A (S. pombe) | 0.033 | ||
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.033 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.033 | ||
| MUC1 | mucin 1, cell surface associated | 0.032 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.032 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.031 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.031 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.031 | ||
| A2M | alpha-2-macroglobulin | 0.031 | ||
| ATP8 | ATP synthase F0 subunit 8 | 0.031 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.031 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.030 | ||
| PTPRA | protein tyrosine phosphatase, receptor type, A | 0.030 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.029 | ||
| HCN1 | hyperpolarization activated cyclic nucleotide-gated potassium channel 1 | 0.029 | ||
| ADAM15 | ADAM metallopeptidase domain 15 | 0.029 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.028 | ||
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.028 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.028 | ||
| ALAS1 | aminolevulinate, delta-, synthase 1 | 0.028 | ||
| ATXN1 | ataxin 1 | 0.027 | ||
| IGFBP4 | insulin-like growth factor binding protein 4 | 0.027 | Human | |
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.027 | ||
| CDC25B | cell division cycle 25 homolog B (S. pombe) | 0.027 | ||
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.026 | ||
| CTGF | connective tissue growth factor | 0.026 | ||
| LGALS4 | lectin, galactoside-binding, soluble, 4 | 0.026 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.026 | ||
| KDM6B | lysine (K)-specific demethylase 6B | 0.026 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.025 | ||
| RALGDS | ral guanine nucleotide dissociation stimulator | 0.025 | ||
| S100A4 | S100 calcium binding protein A4 | 0.025 | ||
| S100A2 | S100 calcium binding protein A2 | 0.025 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.025 | ||
| UBQLN4 | ubiquilin 4 | 0.025 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.025 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.024 | ||
| CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.024 | ||
| GAB2 | GRB2-associated binding protein 2 | 0.024 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.024 | ||
| SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.024 | ||
| JAK1 | Janus kinase 1 | 0.024 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.024 | ||
| APOD | apolipoprotein D | 0.023 | ||
| GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.023 | ||
| VTN | vitronectin | 0.023 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.023 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.023 | ||
| NCOA7 | nuclear receptor coactivator 7 | 0.023 | ||
| LAMC3 | laminin, gamma 3 | 0.022 | ||
| ADAMTSL4 | ADAMTS-like 4 | 0.022 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.022 | ||
| CDK17 | cyclin-dependent kinase 17 | 0.022 | ||
| PEBP1 | phosphatidylethanolamine binding protein 1 | 0.021 | ||
| CD34 | CD34 molecule | 0.021 | ||
| TSC22D3 | TSC22 domain family, member 3 | 0.021 | ||
| SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.021 | ||
| BCKDHA | branched chain keto acid dehydrogenase E1, alpha polypeptide | 0.021 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.020 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.020 | ||
| MAP2 | microtubule-associated protein 2 | 0.020 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.020 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.020 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.020 | ||
| ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.020 | ||
| VAV3 | vav 3 guanine nucleotide exchange factor | 0.020 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.020 | ||
| KRT18 | keratin 18 | 0.019 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.019 | ||
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.019 | ||
| MED15 | mediator complex subunit 15 | 0.019 | ||
| IRS2 | insulin receptor substrate 2 | 0.019 | ||
| TAOK1 | TAO kinase 1 | 0.019 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.019 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.019 | Human | |
| EP300 | E1A binding protein p300 | 0.019 | ||
| MCCC1 | methylcrotonoyl-CoA carboxylase 1 (alpha) | 0.019 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.019 | ||
| MTA3 | metastasis associated 1 family, member 3 | 0.019 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.018 | ||
| BBS7 | Bardet-Biedl syndrome 7 | 0.018 | ||
| ESRRG | estrogen-related receptor gamma | 0.018 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.018 | ||
| PPP1R1A | protein phosphatase 1, regulatory (inhibitor) subunit 1A | 0.017 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.017 | ||
| RANBP3 | RAN binding protein 3 | 0.017 | ||
| SLC13A2 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | 0.017 | ||
| PTN | pleiotrophin | 0.017 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.017 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.017 | ||
| TF | transferrin | 0.017 | Rat | |
| ARC | activity-regulated cytoskeleton-associated protein | 0.017 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.017 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.016 | ||
| CCNB2 | cyclin B2 | 0.016 | ||
| SIK1 | salt-inducible kinase 1 | 0.016 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.016 | ||
| THBD | thrombomodulin | 0.016 | ||
| KLF10 | Kruppel-like factor 10 | 0.016 | ||
| TTR | transthyretin | 0.016 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.016 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.016 | ||
| PKN2 | protein kinase N2 | 0.016 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.016 | ||
| ORM1 | orosomucoid 1 | 0.016 | ||
| HCN4 | hyperpolarization activated cyclic nucleotide-gated potassium channel 4 | 0.015 | ||
| USP11 | ubiquitin specific peptidase 11 | 0.015 | ||
| TM4SF5 | transmembrane 4 L six family member 5 | 0.015 | ||
| PXN | paxillin | 0.015 | ||
| OMP | olfactory marker protein | 0.015 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.015 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.015 | ||
| CUX1 | cut-like homeobox 1 | 0.015 | ||
| E2F1 | E2F transcription factor 1 | 0.015 | ||
| TPPP | tubulin polymerization promoting protein | 0.015 | ||
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.015 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.015 | ||
| PIGR | polymeric immunoglobulin receptor | 0.015 | ||
| PER1 | period homolog 1 (Drosophila) | 0.015 | Mouse | |
| OSMR | oncostatin M receptor | 0.015 | ||
| KCNQ2 | potassium voltage-gated channel, KQT-like subfamily, member 2 | 0.015 | Human | |
| LOXL1 | lysyl oxidase-like 1 | 0.015 | ||
| EMP1 | epithelial membrane protein 1 | 0.014 | ||
| CIDEC | cell death-inducing DFFA-like effector c | 0.014 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.014 | ||
| LMNA | lamin A/C | 0.014 | ||
| RUNX1 | runt-related transcription factor 1 | 0.014 | ||
| CCNA1 | cyclin A1 | 0.014 | ||
| DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0.014 | ||
| TRIB1 | tribbles homolog 1 (Drosophila) | 0.014 | ||
| RHOU | ras homolog gene family, member U | 0.014 | ||
| CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 0.014 | ||
| PTPRN | protein tyrosine phosphatase, receptor type, N | 0.014 | Rat | |
| TFPI2 | tissue factor pathway inhibitor 2 | 0.014 | ||
| RGS16 | regulator of G-protein signaling 16 | 0.014 | ||
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.014 | ||
| SP1 | Sp1 transcription factor | 0.014 | ||
| MGP | matrix Gla protein | 0.014 | ||
| TRIM32 | tripartite motif containing 32 | 0.013 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.013 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.013 | ||
| EGR4 | early growth response 4 | 0.013 | Human | |
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.013 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.013 | ||
| GFAP | glial fibrillary acidic protein | 0.013 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.013 | ||
| PTOV1 | prostate tumor overexpressed 1 | 0.013 | ||
| GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.013 | ||
| FGB | fibrinogen beta chain | 0.013 | ||
| C3 | complement component 3 | 0.013 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.013 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.013 | ||
| RBP4 | retinol binding protein 4, plasma | 0.013 | ||
| RHO | rhodopsin | 0.013 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.013 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.013 | ||
| PTHLH | parathyroid hormone-like hormone | 0.013 | ||
| CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.013 | ||
| ANGPT4 | angiopoietin 4 | 0.013 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.013 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.013 | ||
| SGK2 | serum/glucocorticoid regulated kinase 2 | 0.012 | ||
| INA | internexin neuronal intermediate filament protein, alpha | 0.012 | ||
| AVPR1B | arginine vasopressin receptor 1B | 0.012 | ||
| S100A1 | S100 calcium binding protein A1 | 0.012 | ||
| PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme | 0.012 | ||
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.012 | ||
| BAX | BCL2-associated X protein | 0.012 | ||
| ACHE | acetylcholinesterase | 0.012 | ||
| ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.012 | ||
| NBL1 | neuroblastoma, suppression of tumorigenicity 1 | 0.012 | ||
| LOX | lysyl oxidase | 0.012 | ||
| SP100 | SP100 nuclear antigen | 0.012 | ||
| AQP2 | aquaporin 2 (collecting duct) | 0.012 | Human | |
| DOCK7 | dedicator of cytokinesis 7 | 0.012 | ||
| ZDHHC17 | zinc finger, DHHC-type containing 17 | 0.012 | ||
| GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) | 0.012 | Mouse | |
| CFI | complement factor I | 0.012 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.012 | ||
| FOXO1 | forkhead box O1 | 0.012 | ||
| KCNQ3 | potassium voltage-gated channel, KQT-like subfamily, member 3 | 0.012 | Human | |
| CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.012 | Mouse | |
| PPARG | peroxisome proliferator-activated receptor gamma | 0.012 | ||
| CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.012 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.012 | ||
| GOPC | golgi-associated PDZ and coiled-coil motif containing | 0.012 | ||
| HCRT | hypocretin (orexin) neuropeptide precursor | 0.012 | ||
| E2F3 | E2F transcription factor 3 | 0.012 | ||
| PTRF | polymerase I and transcript release factor | 0.011 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.011 | ||
| STC1 | stanniocalcin 1 | 0.011 | Rat | |
| PITPNM3 | PITPNM family member 3 | 0.011 | ||
| CDT1 | chromatin licensing and DNA replication factor 1 | 0.011 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.011 | ||
| OXT | oxytocin, prepropeptide | 0.011 | Rat | |
| CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.011 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.011 | ||
| RGS1 | regulator of G-protein signaling 1 | 0.011 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.011 | ||
| WDR44 | WD repeat domain 44 | 0.011 | ||
| BMP8A | bone morphogenetic protein 8a | 0.011 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.011 | ||
| IGFBP1 | insulin-like growth factor binding protein 1 | 0.011 | Human | |
| OTUD5 | OTU domain containing 5 | 0.011 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.011 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.011 | ||
| HTRA1 | HtrA serine peptidase 1 | 0.011 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.011 | ||
| ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | 0.011 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.011 | ||
| TRIM11 | tripartite motif containing 11 | 0.011 | ||
| PRKCD | protein kinase C, delta | 0.011 | ||
| HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.011 | ||
| MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.011 | ||
| HADHB | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), beta subunit | 0.011 | ||
| ZFP36L1 | zinc finger protein 36, C3H type-like 1 | 0.011 | ||
| SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | 0.011 | ||
| ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | 0.011 | ||
| NEUROG1 | neurogenin 1 | 0.011 | ||
| C13orf15 | chromosome 13 open reading frame 15 | 0.011 | ||
| ITSN2 | intersectin 2 | 0.011 | ||
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.011 | ||
| AKAP13 | A kinase (PRKA) anchor protein 13 | 0.011 | ||
| INHBB | inhibin, beta B | 0.011 | ||
| C10orf46 | chromosome 10 open reading frame 46 | 0.011 | ||
| DCN | decorin | 0.011 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.011 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.011 | ||
| CUBN | cubilin (intrinsic factor-cobalamin receptor) | 0.011 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.011 | ||
| MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.011 | ||
| DCT | dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) | 0.010 | ||
| GABRG2 | gamma-aminobutyric acid (GABA) A receptor, gamma 2 | 0.010 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.010 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.010 | ||
| FBP2 | fructose-1,6-bisphosphatase 2 | 0.010 | ||
| TUBB6 | tubulin, beta 6 | 0.010 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.010 | ||
| SCNN1G | sodium channel, nonvoltage-gated 1, gamma | 0.010 | ||
| TFF1 | trefoil factor 1 | 0.010 | ||
| PITPNM2 | phosphatidylinositol transfer protein, membrane-associated 2 | 0.010 | ||
| BBS4 | Bardet-Biedl syndrome 4 | 0.010 | ||
| NNMT | nicotinamide N-methyltransferase | 0.010 | ||
| KRT8 | keratin 8 | 0.010 | ||
| CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.010 | ||
| GRIN1 | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | 0.010 | ||
| KCNC3 | potassium voltage-gated channel, Shaw-related subfamily, member 3 | 0.010 | ||
| CNTFR | ciliary neurotrophic factor receptor | 0.010 | ||
| PTGES | prostaglandin E synthase | 0.010 | ||
| C14orf176 | chromosome 14 open reading frame 176 | 0.010 |